Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.56 USD | -0.68% | +5.04% | +45.90% |
10/05 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
09/05 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +2.81% | +5.04% | +45.90% | +134.78% | +102.93% | 4.09B |
- Stock Market
- Equities
- CRNX Stock
- Charts Crinetics Pharmaceuticals, Inc.
- Relative Strength Chart